EnGen Bio

About:

EnGen Bio is a development-stage biotechnology company that pioneers a new approach to preventing and treating influenza.

Website: http://www.engenbio.com/

Top Investors: National Science Foundation

Description:

EnGen Bio is a development-stage biotechnology company that pioneers a new approach to preventing and treating influenza. It believes that it has identified a candidate Universal Type A Influenza vaccine. Influenza drugs and vaccines are unique because there is sufficient government funding available to develop these assets well into human clinical trials, and possibly to market. EnGen Bio is aggressively pursuing this and similar opportunities. It is founded in 2017 and is headquartered in Redwood City, California.